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1. Introduction 51 
Garcinia is one of the largest genera of the Clusiaceae family. Over 300 species are 52 
distributed throughout the tropical and sub-tropical countries [1], with 29 species found in 53 
Thailand [2]. Garcinia plants produce a variety of bioactive compounds [3-8], however, 54 
xanthones and benzophenones were the most common compounds isolated from this genus 55 
[5-11]. These types of compounds have displayed a wide range of biological activities such 56 
as anti-bacterial, cytotoxic, anti-HIV, α-glucosidase inhibitory, antioxidant, anti-57 
inflammatory, antimalarial, and anti-pyretic activities [12-19]. G. nigrolineata is a small to 58 
medium sized tree widely distributed throughout Malaysia, Thailand and Myanmar. Previous 59 
phytochemical investigations, have resulted in the isolation of xanthones along with minor 60 
compounds including benzopyran, biphenyl, benzoquinone and isoflavone derivatives, and 61 
some of these compounds showed antibacterial activity against MRSA [10, 20. 21]. Herein, 62 
we report the isolation and structure elucidation of four new compounds, three xanthones (1-63 
3) and one tocotrienolquinonedimer (4), together with six known compounds (Fig. 1) from the 64 
leaf extract of G. nigrolineata collected from an authentic plant growing in our campus. The 65 
antibacterial activities of all isolated compounds are also reported. 66 
2. Experimental 67 
2.1. General  68 
Melting points were measured on a Buchi melting point B-540 visual thermometer or 69 
Fisher-Johns melting point apparatus. The UV spectra were recorded with a PerkinElmer or 70 
Varian Cary 5000 UV-vis NIR spectrophotometer. IR spectra were recorded on a 71 
PerkinElmer FTS FT-IR spectrometer or a Perkin Elmer Frontier Optica FT-IR 72 
spectrophotometer. The NMR spectra were recorded on 400 MHz Bruker FT-NMR Ultra 73 
Shield and 600 MHz Bruker AV-600 spectrometers with tetramethylsilane as the internal 74 
standard. HRESITOFMS spectra were measured on a Bruker-Hewlett-Packard 1100 Esquire-75 
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LC system mass spectrometer. Quick column chromatography (QCC) and column 76 
chromatography (CC) were performed on silica gel C60 (0-20 µm, SiliCycle® Inc.) and 77 
silica gel G60 (60-200 µm, SiliCycle® Inc.), respectively. Sephadex LH-20, when indicated, 78 
was also used for CC. Precoated TLC plates of silica gel 60 F254 were used for analytical 79 
purposes. 80 
2.2. Plant material 81 
The leaves of G. nigrolineata were collected from the authentic plant growing at Mae 82 
Fah Luang University, Chiang Rai Province, Thailand (GPS coordinates: 20°03'18.8"N 83 
99°53'38.4"E), in January 2018. A voucher specimen (MFU-NPR0187) was deposited at the 84 
Natural Products Research Laboratory of Mae Fah Luang University. 85 
2.3. Extraction and isolation 86 
The fresh leaves of G. nigrolineata (1.3 kg) were extracted with acetone (5 L) at 87 
room temperature (3 days  2) and concentrated under reduced pressure to give an acetone 88 
extract (23.4 g). This extract (23.4 g) was separated by QCC eluting with a gradient solvent 89 
system of n-hexane-acetone (1:0 to 0:1, v/v) to afford six fractions (Fr.1-Fr.6). Fr.1 (3.6 g) 90 
was subjected to Sephadex LH-20 CC eluting with CH2Cl2-MeOH (2:8, v/v) to afford 4 (7.3 91 
mg). Purification of Fr.2 (5.7 g) by silica gel CC eluting with CH2Cl2-n-hexane (3:7, v/v) 92 
gave 5 (5.3 mg), 6 (6.5 mg), and 7 (8.9 mg). Fr.3 (3.5 g) was purified by Sephadex LH-20 93 
CC (100 % MeOH) followed by silica gel CC eluting with EtOAc-n-hexane (4:6, v/v) to 94 
yield 1 (1.5 mg) and 8 (2.6 mg). Fr.4 (1.6 g) was purified by Sephadex LH-20 CC (100 % 95 
MeOH) followed by silica gel CC eluting with MeOH-CH2Cl2 (3:97, v/v) to give 2 (1.4 mg) 96 
and 3 (2.3 mg). Compounds 9 (2.1 mg) and 10 (1.7 mg) were obtained from Fr.6 (2.5 g) by 97 
silica gel CC eluting with acetone-n-hexane (1:1, v/v). 98 
Nigrolineaxanthone X (1): yellow gum, [α]  +24.3 (c 0.1, MeOH), UV (MeOH) λmax 99 
(log ε) 270 (2.57), 322 (2.64), 366 (2.21) nm. IR (KBr) νmax 3377, 2920, 1652, 1617, 1578, 100 
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1451, 1397, 1219, 1126, 1014, 942, 774 cm−1. HRESITOFMS m/z 397.1652 [M + H]+ (calcd 101 
for C23H25O6, 397.1651). 
1H NMR and 13C NMR data, see Table 1. 102 
Nigrolineaxanthone Y (2): yellow powder, mp 255-256 °C, UV (MeOH) λmax (log ε) 103 
267 (4.11), 320 (3.99), 376 (3.69) nm. IR (KBr) νmax 3210, 2967, 1652, 1565, 1348, 1221, 104 
1159, 1113, 785 cm−1. HRESITOFMS m/z 399.1806 [M + H]+ (calcd for C23H27O6, 105 
399.1808). 1H NMR and 13C NMR data, see Table 1.  106 
Nigrolineaxanthone Z (3): yellow powder, mp 220-221 °C, UV (MeOH) λmax (log ε) 107 
248 (3.82), 326 (3.42), 369 (3.29) nm. IR (KBr) νmax 3351, 2969, 2928, 1642, 1581, 1438, 108 
1367, 1224, 904, 771 cm−1. HRESITOFMS m/z 439.1738 [M + Na]+ (calcd for C23H28O7Na, 109 
439.1733).  1H NMR and 13C NMR data, see Table 1.  110 
Nigrolineaquinone B (4): red solid, mp 196-197 °C, [α]  -3.1 (c 0.1, CHCl3); UV-vis 111 
(MeOH) λmax (log ε) 226 (3.48), 324 (3.08), 457 (3.31) nm. IR (KBr) νmax 3439, 2924, 1627, 112 
1569, 1449, 1379, 1259, 1093 cm−1. HRESITOFMS m/z 819.5567 [M + H]+ (calcd for 113 
C54H75O6, 819.5564). 
1H NMR and 13C NMR data, see Table 2.  114 
2.4. Antibacterial assay 115 
The antibacterial assay was determined as recommended by Clinical and Laboratory 116 
Standards Institute [22]. All bacterial strains were obtained from the Microbiological 117 
Resources Center, Bangkok, Thailand. Gentamicin and vancomycin were used as positive 118 
control drugs (Table 3).  119 
3. Results and discussion 120 
The acetone extract was subjected to repeated column chromatography to yield three 121 
undescribed oxygenated xanthones (1-3) and one tocotrienol quinone dimer (4) together with 122 
six known compounds. The known compounds were identified as 8-deoxygartanin (5) [9], 123 
toxyloxanthone A (6) [23], ananixanthone (7) [24], nigrolineaxanthone Q (8) [10], 3-124 
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deoxyquercetin (9) [25] and 3,3,4,5,7-pentahydroxyflavone (10)[26] (Fig. 1 and 3) by 125 
comparison of their physical and spectroscopic data with published values. 126 
Nigrolineaxanthone X (1) was obtained as a yellow gum. A molecular formula of 127 
C23H24O6, was deduced by the combination of its 
1H and 13C NMR and HRESITOFMS data 128 
[m/z 397.1652 [M + H]+ (calcd for C23H25O6, 397.1651)]. The UV spectrum showed 129 
absorption bands at max 270, 322 and 366 nm, which are typical of a xanthone chromophore 130 
[10, 20-21]. The IR spectrum showed stretching bands for hydroxy (3377 cm-1) and carbonyl 131 
(1652 cm-1) functional groups. The 1H and 13C NMR spectroscopic data (Table 1) displayed 132 
resonances for a H-bonded hydroxy proton (H 13.54 (1H, s, OH-1), an ABC spin system of 133 
aromatic protons [H 7.71 (1H, d, J = 7.9 Hz, H-8), 7.36 (1H, d, J = 7.9 Hz, H-6), and 7.30 134 
(1H, t, J = 7.9 Hz, H-7)], a prenyl unit [H 5.32 (1H, t, J = 7.2 Hz, H-2)/C 121.3, 3.34 (2H, 135 
m, H-1)/C 21.0, 1.81 (3H, s, H-4)/C 16.5, 1.68 (3H, s, H-5)/C 25.0, and C 130.7 (C-3)], 136 
and a pyran unit containing OH-2 group [H 4.91(1H, t, J = 8.5 Hz, H-2), 3.41 (2H, m, H-137 
1), 1.31 (3H, s, H-4), and 1.30 (3H, s, H-5)]. The prenyl unit was placed at C-2 due to the 138 
3J HMBC correlations (Fig. 2) of  H2-1 (H 3.34) and OH-1 (H 13.54) to C-2 (C 105.7) 139 
while the pyran unit was attached to C-3/C-4 of the fully substituted aromatic ring from the 140 
HMBC correlations between H2-1 (H 3.41) to C-3 (C 165.4), C-4 (C 103.2), and C-4a (C 141 
149.8). The absolute configuration at C-2 of 1 was postulated as S on the basis of the 142 
positive specific rotation value of 1 ([α]24D +24.3, c 0.1, MeOH) and is consistent with those 143 
of cochinensoxanthone ([α]20D +11, c 0.1, CH2Cl2) [27] and decursinol ([α]
 26
D  +10.3, c 0.1, 144 
CHCl3) [28]. Therefore, 1 was proposed as (2S)-nigrolineaxanthone X.  145 
Nigrolineaxanthone Y (2), a yellow powder, gave an [M + H]+ ion at m/z 399.1806 in 146 
the HRESITOFMS data corresponding to the molecular formula C23H26O6 (calcd for 147 
C23H27O6, 399.1808). The 
1H and 13C NMR data (Table 1) were similar to those of 1 except 148 
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that the C-2 carbinol of 1 was reduced to a C-2 methylene group in 2, which displayed 149 
resonances at H 1.88 (H-2)/C 30.7. Additionally, the Δ2(3) double bond of 1 was hydrated 150 
to generate a 3-hydroxy-3-methylbutyl moiety [H 2.57 (2H, m, H-1)/C 17.2, 1.49 (2H, m, 151 
H-2)/C 42.7, 1.17 (6H, s, H-4 and H-5)/δC 28.9, and δC 69.0 (C-3)] in 2. The HMBC 152 
correlations shown in Figure 2 were fully consistent with the structure of 2.   153 
Nigrolineaxanthone Z (3) was isolated as a yellow powder. The molecular formula 154 
C23H28O7 was established on the basis of HRESITOFMS data [m/z 439.1738 [M+Na]
+ (calcd 155 
for C23H28O7Na, 439.1733)]. The NMR spectroscopic data (Table 1) of 3 were similar to 156 
those of nigrolineaxanthone Y (2), except for the pyran unit which was opened to generate a 157 
3-hydroxy-3-methylbutyl moiety [H/C 3.06 (2H, t, J = 7.8 Hz, H-1)/16.4, 1.82 (2H, t, J = 158 
7.8 Hz, H-2)/41.5, 1.34 (6H, s, H-4 and H-5)/28.3, and C 70.4 (C-3)] in 3.  The 159 
correlation of H-1 (H 3.06) to C-3 (C 160.5), C-4 (C 107.5), and C-4a (C 152.1) in the 160 
HMBC spectrum (Fig. 2) confirmed the location of the 3-hydroxy-3-methylbutyl unit at C-4. 161 
Figure 3 shows a proposed biosynthetic pathway to the xanthones 1-3 and 5-8. The 162 
key intermediate compound 5 has been shown to be produced from compound 11 by double 163 
prenylations at C-2 and C-4 of compound 11 [29]. Hydration of the two prenyl units of 5 164 
would produce 3. Selective epoxidation of the 2-prenyl and 4-prenyl units of 5 would 165 
produce 12 and 13, respectively. Cyclization of 12 would give 1 while cyclization followed 166 
by dehydration of 13would produce 6. Dehydration of 1 would yield 7, which upon reduction 167 
of the pyran ring would give 8. Further hydration of the prenyl unit of 8 would afford 2. 168 
Nigrolineaquinone B (4), a red solid (mp 196-197 C), was assigned the molecular 169 
formula of C54H74O6 based on its molecular ion at m/z 819.5567 [M + H]
+ (calcd for 170 
C54H75O6, 819.5564) in the HRESITOFMS data. The UV-vis spectrum displayed maxima 171 
absorption bands at max 226, 324 and 475 nm while its IR spectrum showed bands for 172 
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hydroxy (3439 cm-1) and carbonyl (1627 cm-1) functionalities. The pyrano-p-quinone 173 
methine skeleton was identified from the following 1H and 13C NMR data: δH/δC 7.76 (1H, s, 174 
H-26/26)/127.5, 7.06 (1H, s, OH-6/6), 6.80 (1H, s, H-7/7)/100.8, 2.53 (2H, m, H-4/4)/15.8, 175 
1.80 (2H, m, H-3/3)/29.3, 1.38 (3H, s, H-25/25)/23.4, and δC 179.8 (C-5/5), 146.9 (C-6/6), 176 
132.3 (C-8/8), 110.8 (C-4a/4a), and 79.3 (C-2/2). The HMBC correlations confirmed the 177 
core structure and are shown in Fig 2. The NOESY cross peak between H-26 (δH 7.76) and 178 
H-7 (δH 6.80) indicated the Z geometry of Δ
8(26) (or Δ8(26)) double bond. The (3E,7E)-4,8,12-179 
trimethyltrideca-3,7,11-trienyl unit  was identified by the combination of data from the 1H, 180 
13C, HSQC, HMBC, and COSY spectra and the comparison of its NMR data with those of 181 
garciniacowol isolated from G. cowa [30]. This unit was placed at C-2 of the main core 182 
structure due to the 2J and 3J HMBC correlations (Fig. 2) of H2-9/9 (1.80, 1H, m, H-9a/9a 183 
and 1.71, 1H, m, H-9b/9b) and H2-10/10 (δH 2.14, 2H, m) to C-2/2 (δC 79.3). The singlet 184 
methyl group resonance at δH 1.38 was assigned to Me-25/25 which was supported by the 185 
HMBC correlation between Me-25/25 and C-2/2 (δC 79.3). The E geometry of Δ
11(12) (or 186 
Δ11(12)) and Δ15(16) (or Δ15(16)) double bonds was confirmed by the NOESY cross peak 187 
between Me-24 (δH 1.59) with H2-10 (δH 2.14) and Me-23 (δH 1.64) with H2-14 (δH 2.08), 188 
respectively. The C54H74O6 molecular formula of 4 along with the observation of only 27 189 
unique 13C NMR resonances indicated that compound was a symmetrical dimer [31]. A small 190 
specific rotation of 4 ([α]  -3.1 (c 0.1, CHCl3) indicated that the configuration at C-2/C-2 191 
should be racemic. A possible biosynthetic pathway for 4 (Fig. 4) starts from geranylgeranyl-192 
PP and homogentisic acid [32]. Oxidation of 14 could give the para quinone methide 15 193 
which could dimerize resulting in the C-C bond formation of 17 via the intermediate 16. 194 
Further oxidation of 17 would afford 4. 195 
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All isolated compounds were tested for their antibacterial activities (Table 3) against 196 
Gram-positive (Bacillus cereus, Micrococcus luteus, Staphylococcus aureus, Staph. 197 
epidermidis, and Streptococcus mutans) and Gram-negative (Escherichia coli, Pseudomonas 198 
aeruginosa, Salmonella typhimurium, and Shigella flexneri) bacteria. Unfortunately, only 199 
compound 8 demonstrated moderate antibacterial activities against M. luteus with a MIC 200 
value of 8 μg/mL. All other compounds were found to have weak activities (MIC 32-128 201 
μg/mL) or were inactive against both Gram-positive and Gram-negative bacteria. 202 
Conflict of interest 203 
The authors declare no competing financial interest. 204 
Acknowledgments 205 
We are grateful to the Thailand Research Fund and Mae Fah Luang University for 206 
financial support (BRG5980012). University of British Columbia is also acknowledged for 207 
laboratory facilities. 208 
Appendix A. Supplementary data 209 
Supplementary data associated with this article can be found, in the online version. 210 
References 211 
[1] A. Kijjoa, L.M.M. Vieira, Triterpenes from the plants of the family Clusiaceae 212 
(Guttiferae): Chemistry and biological activities, in Natural products: Chemistry, 213 
Biochemistry and Pharmacology, (Ed. G. Brahmachari), Alpha Science International 214 
Ltd., Oxford, 2009, Ch.13. 215 
[2] T. Ritthiwigrom, S. Laphookhieo, S.G. Pyne, Chemical constituents and biological 216 
activities of Garcinia cowa Roxb, Maejo Int. J. Sci. Tech. 7 (2013), 212−231. 217 
[3] M. Masullo, C. Bassarello, H. Suzuki, et al., Polyisoprenylated benzophenones and an 218 
unusual polyisoprenylated tetracyclic xanthone from the fruits of Garcinia cambogia, 219 
J. Agric. Food Chem. 56 (2008), 5205−5210. 220 
10 
 
[4] V. Rukachaisirikul, S. Saelim, P. Karnsomchoke, et al., Friedolanostanes and 221 
lanostanes from the leaves of Garcinia hombroniana, J. Nat. Prod. 68 (2005), 222 
1222−1225. 223 
[5] T. Sriyatep, W. Maneerat, T. Sripisut, et al., Cowabenzophenones A and B, two new 224 
tetracyclo [7.3.3.33,11.03,7] tetradecane-2, 12, 14-trione derivatives, from ripe fruits of 225 
Garcinia cowa, Fitoterapia 92 (2004), 285−289. 226 
[6] C.-C. Wu, Y.-H. Lu, B.-L. Wei, et al., Phloroglucinols with prooxidant activity from 227 
Garcinia subelliptica, J. Nat. Prod. 71 (2008), 246−250. 228 
[7] H. Yang, M. Figueroa, S. To, et al., Benzophenones and biflavonoids from Garcinia 229 
livingstonei fruits, J. Agric. Food Chem. 58 (2010), 4749−4755. 230 
[8] M. Yoshimura, K. Ninomiya, Y. Tagashira, et al., Polyphenolic constituents of the 231 
pericarp of mangosteen (Garcinia mangostana L.), J. Agric. Food Chem. 63 (2015), 232 
7670−7674. 233 
[9] L.-H. Nguyen, H.T. Vo, H.D. Pham, et al., Xanthones from the bark of Garcinia 234 
merguensis, Phytochemistry 63 (2003), 467−470. 235 
[10] V. Rukachaisirikul, M. Kamkaew, D. Sukavisit, et al., Antibacterial xanthones from the 236 
leaves of Garcinia nigrolineata, J. Nat. Prod. 66 (2003), 1531−1535. 237 
[11] T. Sriyatep, R.J. Andersen, B.O. Patrick, et al., Scalemic caged xanthones isolated from 238 
the stem bark extract of Garcinia propinqua, J. Nat. Prod. 80 (2017), 1658−1667. 239 
[12] P.S. Negi, G.K. Jayaprakasha, B.S. Jena,  Antibacterial activity of the extracts from the 240 
fruit rinds of Garcinia cowa and Garcinia pedunculata against food borne pathogens 241 
and spoilage bacteria, LWT - Food Sci. Technol. 41 (2008), 1857−1861. 242 
11 
 
[13] P. Pailee, C. Kuhakarn, C. Sangsuwan, et al., Anti-HIV and cytotoxic biphenyls, 243 
benzophenones and xanthones from stems, leaves and twigs of Garcinia speciosa, 244 
Phytochemistry 147 (2018), 68−79. 245 
[14] H.W. Ryu, S.H. Jeong, M.J. Curtis-Long, et al., Inhibition effects of mangosenone F 246 
from Garcinia mangostana on melanin formation in B16F10 cells, J. Agric. Food 247 
Chem.  60 (2012), 8372−8378. 248 
[15] H.-A. Jung, B.-N. Su, W. J. Keller, et al., Antioxidant xanthones from the pericarp of 249 
Garcinia mangostana (mangosteen), J. Agric. Food Chem. 54 (2006), 2077−2082. 250 
[16] T.D. Stark, T. Matsutomo, S. Lösch, et al., Hofmann, Isolation and structure 251 
elucidation of highly antioxidative 3,8″-linked biflavanones and flavanone-C-252 
glycosides from Garcinia buchananii bark, J. Agric. Food Chem. 60 (2012), 253 
2053−2062. 254 
[17] Y. Fu, H. Zhou, M. Wang, et al., Immune regulation and anti-inflammatory effects of 255 
isogarcinol extracted from Garcinia mangostana L. against collagen-induced arthritis, 256 
J. Agric. Food Chem. 62 (2014), 4127−4134. 257 
[18] A. Panthong, P. Norkaew, D. Kanjanapothi et al., Anti-inflammatory, analgesic and 258 
antipyretic activities of the extract of gamboge from Garcinia hanburyi Hook f., J. 259 
Ethnopharmacol. 111 (2007), 335−340. 260 
[19] W. Chaijaroenkul, M.A. Mubaraki, S.A. Ward, et al., Metabolite footprinting of 261 
Plasmodium falciparum following exposure to Garcinia mangostana Linn. crude 262 
extract,  Exp. Parasitol. 145 (2014), 80−86. 263 
[20] V. Rukachaisirikul, T. Ritthiwigrom, A. Pinsa, et al., Xanthones from the stem bark of 264 
Garcinia nigrolineata, Phytochemistry 64 (2003), 1149−1156. 265 
12 
 
[21] V. Rukachaisirikul, K. Tadpetch, A. Watthanaphanit, et al., Benzopyran, biphenyl, and 266 
tetraoxygenated xanthone derivatives from the twigs of Garcinia nigrolineata, J. Nat. 267 
Prod. 68 (2005), 1218−1221. 268 
[22] CLSI. Reference Method for Dilution Antimicrobial Susceptibility Test for Bacteria 269 
that Grow Aerobically: Approved Standard M07-A9. Clinical and Laboratory 270 
Standards Institute: Wayne, PA, 2012.  271 
[23] V.H. Deshpande, A.V.R. Rao, M. Varadan, et al., Wood & bark phenolics of Maclura 272 
pomifera: four new xanthones, Indian J. Chem. 11 (1973), 518−524. 273 
[24] J.C. Bayma, M.S.P. Arruda, M.S. Neto, A prenylated xanthone from the bark of 274 
Symphonia globulifera, Phytochemistry 49 (1998), 1159−1160. 275 
[25] L. Ruiz-Vásquez, M. Reina, M. López-Rodríguez, et al., González-Coloma, 276 
Sesquiterpenes, flavonoids, shikimic acid derivatives and pyrrolizidine alkaloids from 277 
Senecio kingii Hook,  Phytochemistry 117 (2015), 245−253. 278 
[26] A.M. Adelekan, E.A. Prozesky, A.A. Hussein, et al., Bioactive diterpenes and other 279 
constituents of Croton steenkampianus,  J. Nat. Prod. 71 (2008), 1919−1922. 280 
[27] Y. Ren, S. Matthew, D.D. Lantvit, et al., Cytotoxic and NF-κB inhibitory constituents 281 
of the stems of Cratoxylum cochinchinense and their semisynthetic analogues, J. Nat. 282 
Prod. 74 (2011), 1117−1125. 283 
[28] J.H. Lee, H.B. Bang, S.Y. Han, et al., An efficient synthesis of (+)-decursinol from 284 
umbelliferone, Tetrahedron Lett. 48 (2007), 2889−2892. 285 
[29] W. Schmidt, L. Beerhues.  Alternative pathways of xanthone biosynthesis in cell 286 
cultures of Hypericum androsaemum L., FEBS Letters 420 (1997), 143−146. 287 
13 
 
[30] I. Siridechakorn, W. Phakodee, T. Ritthiwigrom, et al., Antibacterial 288 
dihydrobenzopyran and xanthone derivatives from Garcinia cowa stem barks, 289 
Fitoterapia 83 (2012), 1430−1434. 290 
[31] A. Lavaud, P. Richomme, J. Gatto, et al., A tocotrienol series with an oxidative 291 
terminal prenyl unit from Garcinia amplexicaulis, Phytochemistry 109 (2015), 292 
103−110. 293 
[32] W. Yang, R.E. Cahoon, S. Hunter, et al., Vitamin E biosynthesis: functional 294 
characterization of the monocot homogentisate geranylgeranyl transferase, Plant J. 65 295 
(2011), 206−217. 296 
 297 
